Format

Send to

Choose Destination
JAMA Intern Med. 2018 Jun 1;178(6):743-744. doi: 10.1001/jamainternmed.2018.0869.

Concerns About the Approval of Nusinersen Sodium by the US Food and Drug Administration.

Author information

1
Division of General Internal Medicine and Geriatrics, Oregon Health & Sciences University, Portland.
2
Division of Hematology Oncology, Knight Cancer Institute, Portland, Oregon.
3
Center for Health Care Ethics, Oregon Health & Sciences University, Portland.

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center